3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Neoplasms
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Immunoproliferative Disorders
1
Congenital Abnormalities
1
Burkitt Lymphoma
1
Interventions
Rituximab
4
Lenalidomide
2
Crizotinib
2
Bendamustine Hydrochloride
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
sapanisertib
1
relatlimab
1
polatuzumab vedotin
1
pirtobrutinib
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
obinutuzumab
1
larotrectinib
1
ipatasertib
1
idelalisib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vincristine
1
Trastuzumab
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Lymphoma
×
Daunorubicin
×
Clear all
No trials found.